These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 27647070)

  • 1. [Advances in the research of treating multi-drug resistant bacterial infections].
    Peng Y; Fu YX
    Zhonghua Shao Shang Za Zhi; 2016 Sep; 32(9):539-41. PubMed ID: 27647070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IMAP 2012: Antimicrobial peptides to combat (multi)drug-resistant pathogens.
    Adermann K; Hoffmann R; Otvos L
    Protein Pept Lett; 2014 Apr; 21(4):319-20. PubMed ID: 24164271
    [No Abstract]   [Full Text] [Related]  

  • 3. New antimicrobial agents for the treatment of bacterial infections in cancer patients.
    Rolston KV
    Hematol Oncol; 2009 Sep; 27(3):107-14. PubMed ID: 19569253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Editorial: Reviews in antibiotic resistance and new antimicrobial drugs.
    Kaushik S
    Front Cell Infect Microbiol; 2024; 14():1434140. PubMed ID: 38895736
    [No Abstract]   [Full Text] [Related]  

  • 5. Repositioning of non-antibiotic drugs as an alternative to microbial resistance: a systematic review.
    Foletto VS; da Rosa TF; Serafin MB; Bottega A; Hörner R
    Int J Antimicrob Agents; 2021 Sep; 58(3):106380. PubMed ID: 34166776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Silver nanoparticles: the powerful nanoweapon against multidrug-resistant bacteria.
    Rai MK; Deshmukh SD; Ingle AP; Gade AK
    J Appl Microbiol; 2012 May; 112(5):841-52. PubMed ID: 22324439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reasons for antimicrobial treatment failures and predictive value of in-vitro susceptibility testing in veterinary practice: An overview.
    Richter A; Feßler AT; Böttner A; Köper LM; Wallmann J; Schwarz S
    Vet Microbiol; 2020 Jun; 245():108694. PubMed ID: 32456814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Losing ground: multidrug-resistant bacteria in solid-organ transplantation.
    Herati RS; Blumberg EA
    Curr Opin Infect Dis; 2012 Aug; 25(4):445-9. PubMed ID: 22766649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Late stage antibacterial drugs in the clinical pipeline.
    Projan SJ; Bradford PA
    Curr Opin Microbiol; 2007 Oct; 10(5):441-6. PubMed ID: 17950658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The challenge of antibiotic resistant bacterial pathogens: the medical need, the market and prospects for new antimicrobial agents.
    Payne D; Tomasz A
    Curr Opin Microbiol; 2004 Oct; 7(5):435-8. PubMed ID: 15451496
    [No Abstract]   [Full Text] [Related]  

  • 11. Novel antimicrobial peptide CPF-C1 analogs with superior stabilities and activities against multidrug-resistant bacteria.
    Xie J; Zhao Q; Li S; Yan Z; Li J; Li Y; Mou L; Zhang B; Yang W; Miao X; Jiang X; Wang R
    Chem Biol Drug Des; 2017 Nov; 90(5):690-702. PubMed ID: 28371431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multi-resistant bacteria in spontaneous bacterial peritonitis: a new step in management?
    de Mattos AA; Costabeber AM; Lionço LC; Tovo CV
    World J Gastroenterol; 2014 Oct; 20(39):14079-86. PubMed ID: 25339797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic potential of host defense peptides in antibiotic-resistant infections.
    Afacan NJ; Yeung AT; Pena OM; Hancock RE
    Curr Pharm Des; 2012; 18(6):807-19. PubMed ID: 22236127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bisphosphocins: novel antimicrobials for enhanced killing of drug-resistant and biofilm-forming bacteria.
    Wong JP; DiTullio P; Parkinson S
    Future Microbiol; 2015; 10(11):1751-8. PubMed ID: 26597426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multidrug-resistant organisms and antibiotic management.
    Barie PS
    Surg Clin North Am; 2012 Apr; 92(2):345-91, ix-x. PubMed ID: 22414417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An overview of antimicrobial peptides and the latest advances in their development.
    Sierra JM; Fusté E; Rabanal F; Vinuesa T; Viñas M
    Expert Opin Biol Ther; 2017 Jun; 17(6):663-676. PubMed ID: 28368216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advances in Engineered Nano-Biosensors for Bacteria Diagnosis and Multidrug Resistance Inhibition.
    Xia Q; Jiang H; Liu X; Yin L; Wang X
    Biosensors (Basel); 2024 Jan; 14(2):. PubMed ID: 38391978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coping with antibiotic resistance: combining nanoparticles with antibiotics and other antimicrobial agents.
    Allahverdiyev AM; Kon KV; Abamor ES; Bagirova M; Rafailovich M
    Expert Rev Anti Infect Ther; 2011 Nov; 9(11):1035-52. PubMed ID: 22029522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. What's new in the antibiotic pipeline.
    Lee VJ; Miller GH; Yagisawa M
    Curr Opin Microbiol; 1999 Oct; 2(5):475-82. PubMed ID: 10508732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibiotic Adjuvants: A Promising Approach to Combat Multidrug Resistant Bacteria.
    Sharma N; Chhillar AK; Dahiya S; Choudhary P; Punia A; Gulia P
    Curr Drug Targets; 2021; 22(12):1334-1345. PubMed ID: 33494671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.